Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital.

Background: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting.

Purpose: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India.

Synopsis: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality.